Impact of Guidance on the Prescription Patterns of G-CSFs for the Prevention of Febrile Neutropenia Following Anticancer Chemotherapy: A Population-Based Utilization Study in the Lazio Region

BACKGROUND: Current guidelines recommend prophylaxis with granulocyte colony-stimulating factors (G-CSFs) for patients with cancer who are at greater risk of febrile neutropenia (FN) while receiving chemotherapy. G-CSF biosimilars are available and represent a savings opportunity; however, their upt...

Descripción completa

Detalles Bibliográficos
Autores principales: Trotta, Francesco, Mayer, Flavia, Mecozzi, Alessandra, Amato, Laura, Addis, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380704/
https://www.ncbi.nlm.nih.gov/pubmed/28353170
http://dx.doi.org/10.1007/s40259-017-0214-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380704/
https://www.ncbi.nlm.nih.gov/pubmed/28353170
http://dx.doi.org/10.1007/s40259-017-0214-9

Ejemplares similares